BTG Plc is an international healthcare specialist company that develops and commercializes products that target cancer, critical care, varicose veins, and other disorders. It was founded in 1991 as British Technology Group Ltd. The events leading to its formation began with the merging of the National Research Development Corporation formerly established in 1948, and the National Enterprise Board formed in 1975. Its headquarters is in London, United Kingdom.

It is categorized in the healthcare industry where it performs its business by manufacturing, developing, and marketing special medical innovations dealing with the healthcare areas as earlier mentioned. BTG also gets royalty payments from partners’ products, and from these makes its alternative revenue.

It basically provides new ways of treatment of diseases; giving patients a difference, and being invaluable in healthcare provision in the society. The BTG Plc is listed on the London Stock Exchange, where it trades as BTG International Ltd.

Latest BTG News

BTG Share Price: Company Expects To Hit Top End Of Revenue Guidance

Healthcare company BTG PLC Tuesday reported higher pretax profit for the first half of its financial year, driven by acquisitions in its interventional medicine unit and strong growth in its specialty pharmaceuticals business, and said it now expects full-year revenue...

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.